Inventor
Laura A. Hexamer
Inventor
Grayslake, IL, US
Overview
Patents· 21 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
C07DHeterocyclic compounds31%
A61KPreparations for medical, dental or toiletry purposes24%
C07CAcyclic or carbocyclic compounds7%
Y02ATechnologies for adaptation to climate change6%
PatentTitleYear
9,315,488'Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases'20169,303,025'Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases'20169,174,982'Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases'20159,156,856'Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases'20159,125,913'Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases'20159,072,748'BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases'20159,073,855'BCL-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseases'20159,045,420'Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases'20159,029,404'Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases'20158,952,157'Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases'20158,586,754'BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases'20138,563,735'Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases'20138,557,983'Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases'20138,546,399'Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases'20138,426,422'Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases'20138,343,967'Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases'20138,338,466'Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases'20128,188,077'Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases'20128,148,384'Substituted thieno[3,2-d]pyrimidine PIM kinase inhibitors as cancer chemotherapeutics'20127,956,185'Cyclobut-3-ene-1,2,-dione inhibitors of polo-like kinases'20117,456,169'Heterocyclic kinase inhibitors'2008Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2008Based in Gurnee, IL, US· patent location history
2011–2016Based in Grayslake, IL, US· patent location history
2012–2013Patents assigned to SULLIVAN GERARD M (8)· patent assignee history
2012–2013Patents assigned to ELMORE STEVEN W (7)· patent assignee history
2012–2013Patents assigned to SOUERS ANDREW J (7)· patent assignee history
2012–2013Patents assigned to WENDT MICHAEL D (7)· patent assignee history
2013–2016Patents assigned to ABBVIE INC (15)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ABBVIE INC | 15 | 2013–2016 |
| SULLIVAN GERARD M | 8 | 2012–2013 |
| ELMORE STEVEN W | 7 | 2012–2013 |
| SOUERS ANDREW J | 7 | 2012–2013 |
| WENDT MICHAEL D | 7 | 2012–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Grayslake, Illinois, US | 20 | 2011–2016 |
| Gurnee, Illinois, US | 1 | 2008 |